Skip to main content
. 2017 May 5;22(4):303–309. doi: 10.1016/j.rpor.2017.02.011

Fig. 3.

Fig. 3

(a) The correlation between the biologically effective doses for the whole liver and the PTV. X and Y axes indicate the mean BED2 for liver (Gy) and the proportion of PTV (circles; the solid line denotes the standard curve) and that of the overlap between the PTV and the liver (squares; the dashed line denotes the standard curve) in the whole liver, respectively. (b) The correlation between the potential liver dysfunctional volume (cm3) (Y axis) and the intersection volume between the PTV and the liver (cm3) (X axis). The circles (with the solid line denoting the standard curve) indicate the liver volumes that received a BED2 of 50 Gy or greater. The squares (with the dashed line denoting the standard curve) indicate the liver volumes that received a BED2 of 75 Gy or greater PTV = planning target volume, BED = biologically effective dose.